2016-02-10T14:07:13-06:00 2015-06-30 131459550 WEISERMAZARS LLP 135 WEST 50TH STREET NEW YORK NY 100201299 990 2014-07-01 133060086 THE SLE LUPUS FOUNDATION SLEL 2126854118 330 SEVENTH AVENUE NO 1701 NEW YORK NY 10001 MARGARET DOWD EXECUTIVE DIRECTOR 2126854118 2016-02-09 1 ISRAEL TANNENBAUM P01589203 2128127000 2014 2016-08-17 19:52:53Z MARGARET DOWD 330 SEVENTH AVENUE NEW YORK NY 10001 2524977 0 X N/A X 1977 NY RESEARCH CAUSES & CURE OF LUPUS ERYTHEMATOSUS 18 18 25 18 0 0 1532582 844415 0 0 9 34 1835145 1204674 3367736 2049123 164811 1107996 0 0 1324483 1021910 0 0 275371 1512659 487480 3001953 2617386 365783 -568263 1560941 850617 203869 61808 1357072 788809 RESEARCH CAUSES & CURE OF LUPUS ERYTHEMATOSUS 0 0 1107996 1107996 GRANTS & FELLOWSHIPS - ENCOURAGE RESEARCH TO DISCOVER CAUSES AND CURE OF LUPUS ERYTHEMATOSUS, INCLUDING GRANTS TO AN AFFILIATE FOR RESEARCH 961876 PUBLIC AWARENESS, PATIENT SUPPORT, PROMOTE UNDERSTANDING BY THE GENERAL PUBLIC THROUGH EDUCATION AND SUPPORT 2069872 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 20 0 1 25 1 0 0 0 0 0 1 1 0 0 0 0 X 18 18 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 0 1 1 0 NY CA X THE SLE LUPUS FOUNDATION 2126854118 330 SEVENTH AVENUE SUITE 1701 NEW YORK NY 10001 MARGARET DOWD EXEC. DIR. 16.00 24.00 X X 84145 126218 22143 RICHARD K DESCHERER PRESIDENT 5.00 1.00 X X 0 0 0 SUSAN GOLICK VICE PRESIDENT 5.00 1.00 X X 0 0 0 ROBERT RAVITZ VICE PRESIDENT 5.00 1.00 X X 0 0 0 MARY BELLE DIRECTOR 1.00 X 0 0 0 JEROME A CHAZEN DIRECTOR 1.00 1.00 X 0 0 0 BRUCE CRONSTEIN MD DIRECTOR 1.00 X 0 0 0 JENNIE DESCHERER DIRECTOR 1.00 1.00 X 0 0 0 TUHINA DE O'CONNOR DIRECTOR 1.00 X 0 0 0 HEIDI FISKE DIRECTOR 1.00 X 0 0 0 MICHELLE GADSDEN-WILLIAMS DIRECTOR 1.00 X 0 0 0 CHARLES OSGOOD DIRECTOR 1.00 X 0 0 0 CHRIS PARADYSZ DIRECTOR 1.00 X 0 0 0 BONNIE ENGLEBARDT LAUTENBERG DIRECTOR 1.00 X 0 0 0 JESSYE NORMAN DIRECTOR 1.00 X 0 0 0 FERN TESSLER DIRECTOR 1.00 X 0 0 0 ALAN J WASSERMAN DDS DIRECTOR 1.00 X 0 0 0 TERI WILFORD WOOD DIRECTOR 1.00 X 0 0 0 CAROL WEISMAN DIRECTOR 1.00 X 0 0 0 MARGY MEISLIN DEVELOPMENT 16.00 24.00 X 57019 85528 18682 ANDREA O'NEILL DIRECTOR OF DEVELOPMENT 28.00 12.00 X 115360 49440 8240 DOREY NEILINGER GIFT OFFICER 12.00 28.00 X 43767 102124 18920 DIANE GROSS DEVELOPMENT 32.00 8.00 X 81411 20353 16713 381702 383663 84698 1 0 1 0 0 5320 514214 59000 265881 41226 844415 34 34 1674390 514214 475854 1198536 1198536 SUNDRY 900099 6138 6138 6138 2049123 6138 0 1198570 1107996 1107996 94264 56560 18852 18852 744959 405456 173903 165600 31857 17202 6119 8536 95517 52303 22108 21106 55313 30421 12722 12170 900 675 117 108 24617 18463 3200 2954 57925 43386 7386 7153 57085 42047 5505 9533 16096 11912 1693 2491 160532 119485 18582 22465 1283 962 167 154 7136 5209 571 1356 15227 11116 1218 2893 COMMUNITY PROGRAM DEVEL 132879 132879 PUBLIC AWARENESS 12238 12238 NEWSLETTER 1197 1197 DUES 365 365 2617386 2069872 272143 275371 273412 123268 887775 620373 292918 63762 66591 10105 171875 166845 12166 5030 28079 28079 1560941 850617 21309 26954 47500 45060 34854 90000 0 203869 61808 X 1357072 788809 1357072 788809 1560941 850617 -568263 0 X 0 1 X 1 0 X 1007869 1484140 1710074 1532582 844415 6579080 1007869 1484140 1710074 1532582 844415 6579080 1552449 5026631 897 273 270 310 34 1784 59896 37717 24351 26729 6138 154831 6735695 10089920 0.74630 0.77210 X PART II LINE 10 SUNDRY INCOME RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 171875 166845 5030 5030 X 2049123 0 2049123 0 2049123 2617386 0 2617386 0 2617386 PART X, LINE 2: MANAGEMENT IS NOT AWARE OF ANY ISSUES OR CIRCUMSTANCES THAT WOULD UNFAVORABLY IMPACT ITS TAX EXEMPT STATUS. MANAGEMENT HAS DETERMINED THAT IT HAS NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION. THE FOUNDATION IS NO LONGER BEING SUBJECT TO EXAMINATION FOR YEARS BEFORE 2011. FALL GALA EVENT 1758484 514214 1244270 360227 NY BAG LADIES LUNCHEON 337835 337835 85845 2 92285 92285 29782 2188604 514214 1674390 475854 475854 1198536 1 NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501 (C) (3) 50000 RESEARCH FOR CAUSES AND CURE OF LUPUS ERYTHEMATOSUS FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH 5 DAKOTA DRIVE LAKE SUCCESS NY 11042 112673595 501 (C) (3) 47500 RESEARCH FOR CAUSES AND CURE OF LUPUS ERYTHEMATOSUS LUPUS RESEARCH INSTITUTE 330 SEVENTH AVENUE NEW YORK NY 10001 061565950 501 (C) (3) 1000000 RESEARCH FOR CAUSES AND CURE OF LUPUS ERTHEMATOSUS 3 0 SCHEDULE I PART 1 LINE 2 THE FOUNDATION RECEIVES REPORTS ANNUALLY FROM THE GRANTEE AS TO WHAT THE FUNDS WERE USED FOR BEFORE IT PAYS THE NEXT INSTALMENT PAYMENT IN GRANTS EXCEEDING ONE YEAR. X 0 0 0 0 0 0 0 0 0 MARGARET DOWD EXEC. DIR. 84145 126218 0 0 0 0 4207 6311 4650 6975 93002 139504 0 0 MARGY MEISLIN DEVELOPMENT 57019 85528 0 0 0 0 2823 4234 4650 6975 64492 96737 0 0 ANDREA O'NEILL DIRECTOR OF DEVELOPMENT 115360 49440 0 0 0 0 0 0 5768 2472 121128 51912 0 0 DOREY NEILINGER GIFT OFFICER 43767 102124 0 0 0 0 2189 5106 3487 8138 49443 115368 0 0 X 2 41226 FAIR MARKET VALUE 0 0 1 PART I, COLUMN (B): THERE WERE 2 CONTRIBUTORS OF NONCASH CONTRIBUTIONS. PART I, LINE 32B: THE FOUNDATION USES A CUSTODIAN TO PROCESS NONCASH CONTRIBUTIONS. FORM 990, PART VI, SECTION A, LINE 2 RICHARD AND JENNIE DESCHERER ARE HUSBAND AND WIFE ALAN WASSERMAN, D.D.S. AND SUSAN GOLICK ARE HUSBAND AND WIFE FORM 990, PART VI, SECTION B, LINE 11 A COPY OF FORM 990 IS PROVIDED TO THE TREASURER FOR REVIEW BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C EACH NEW BOARD MEMBER AND ANNUALLY THEREAFTER SHALL SIGN A STATEMENT AFFIRMING THAT HE OR SHE HAS RECEIVED A COPY OF THIS POLICY, HAS READ AND UNDERSTANDS THIS POLICY, HAS AGREED TO COMPLY WITH THIS POLICY, AND UNDERSTANDS THAT THE ORGANIZATION IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. THE SECRETARY OF THE BOARD RECEIVES THE STATEMENTS AND REVIEWS AND SHARES THEM WITH EITHER THE AUDIT COMMITTEE OR THE BOARD. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION OF THE EXECUTIVE DIRECTOR IS DETERMINED BY REVIEW AND APPROVAL BY THE BOARD PRESIDENT. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY REVIEW AND APPROVAL OF THE EXECUTIVE DIRECTOR, BOARD PRESIDENT AND BOARD TREASURER. COMPENSATION WAS LAST REVIEWED ON 1/1/15. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. LUPUS RESEARCH INSTITUTE 330 SEVENTH AVENUE NEW YORK NY 10001 061565950 RESEARCH TO DISCOVER CAUSES, TREATMENT AND CURE OF LUPUS ERYTHEMATOSUS NY 501(C)(3) 170(B)(1)(A)(VI) N/A 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0